BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC)

Historical Holders from Q2 2019 to Q4 2025

Type / Class
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
Symbol
BCYC on Nasdaq
Shares outstanding
49,720,826
Price per share
$7.08
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
36,906,185
Holdings value
$285,619,779
% of all portfolios
0%
Share change
-4,294,502
Value change
-$29,768,276
Average buys %
+0%
Average sells %
-0%
Number of holders
99
Price from insider filings
$7.44
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Forbion Growth Opportunities Fund II Cooperatief U.A. 7.3% $22,543,715 3,452,330 Forbion Growth Opportunities Fund II Cooperatief U.A. 21 Nov 2024
WESTFIELD CAPITAL MANAGEMENT CO LP 5.5% $17,045,501 2,610,337 Westfield Capital Management Company, L.P. 31 Dec 2024
ARMISTICE CAPITAL, LLC 10% $17,544,046 2,284,381 Armistice Capital, LLC 30 Jun 2025
Point72 Asset Management, L.P. 3.9% -49% $14,287,235 -$14,430,728 1,860,317 -50% Point72 Asset Management, L.P. 30 Jun 2025
Deep Track Capital, LP 2.4% -54% $9,240,914 -$12,425,679 1,203,244 -57% Deep Track Capital, LP 30 Jun 2025
As of 30 Sep 2025, BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) has 99 institutional shareholders filing 13F forms. They hold 36,906,185 shares of 49,720,826 outstanding shares (74%) .

Top 25 institutional shareholders own 70% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BAKER BROS. ADVISORS LP 22% 10,885,357 0% 0.61% $84,252,663
FCPM III SERVICES B.V. 6.9% 3,452,330 0% 5.3% $26,721,034
ARMISTICE CAPITAL, LLC 6% 2,978,000 +6.4% 0.72% $23,049,720
WESTFIELD CAPITAL MANAGEMENT CO LP 5.9% 2,952,543 +6.2% 0.1% $22,852,683
Siren, L.L.C. 4% 2,012,752 0% 0.61% $15,578,700
Long Focus Capital Management, LLC 2.9% 1,418,695 +7.7% 0.64% $10,980,699
PRICE T ROWE ASSOCIATES INC /MD/ 2.8% 1,384,794 -5.7% 0% $10,719,000
ACADIAN ASSET MANAGEMENT LLC 2.6% 1,314,556 +88% 0.02% $10,155,000
Candriam S.C.A. 2.4% 1,172,387 0% 0.05% $9,074,275
PRINCIPAL FINANCIAL GROUP INC 2.3% 1,148,402 +65% 0% $8,888,631
MILLENNIUM MANAGEMENT LLC 2.1% 1,054,746 -27% 0.01% $8,163,734
MORGAN STANLEY 1.7% 822,705 -21% 0% $6,367,736
BANK OF AMERICA CORP /DE/ 1.2% 591,535 -29% 0% $4,578,482
RENAISSANCE TECHNOLOGIES LLC 1% 518,700 +63% 0.01% $4,014,738
SILVERCREST ASSET MANAGEMENT GROUP LLC 0.96% 476,976 +80% 0.02% $3,691,794
Point72 Asset Management, L.P. 0.87% 430,900 -76% 0.01% $3,335,166
Jefferies Financial Group Inc. 0.81% 401,926 -13% 0.03% $3,110,907
BlackRock, Inc. 0.57% 282,418 +6.8% 0% $2,185,916
Palo Alto Investors LP 0.44% 221,071 -11% 0.32% $1,711,090
Legal & General Group Plc 0.4% 197,917 +13% 0% $1,531,879
PINNACLE ASSOCIATES LTD 0.4% 196,618 +14% 0.02% $1,521,823
Eversept Partners, LP 0.39% 194,440 -8.1% 0.12% $1,504,966
CITADEL ADVISORS LLC 0.38% 189,027 +36% 0% $1,463,069
PLATINUM INVESTMENT MANAGEMENT LTD 0.37% 184,603 -35% 0.09% $1,428,827
TWO SIGMA INVESTMENTS, LP 0.37% 184,537 +228% 0% $1,428,316

Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 1,386 $9,813 -$5,168 $7.08 1
2025 Q3 36,906,185 $285,619,779 -$29,768,276 $7.74 99
2025 Q2 41,200,406 $286,338,478 -$7,404,276 $6.95 110
2025 Q1 41,735,285 $354,350,748 -$8,364,991 $8.49 95
2024 Q4 41,889,461 $586,461,677 -$21,541,145 $14.00 95
2024 Q3 40,439,351 $915,266,321 +$21,085,243 $22.63 105
2024 Q2 39,722,353 $803,967,252 +$167,245,373 $20.24 106
2024 Q1 30,475,266 $758,677,656 -$4,806,815 $24.90 94
2023 Q4 204,482 $3,705,574 +$624,638 $18.08 3
2023 Q3 32,399,962 $650,898,671 +$162,226,164 $20.09 98
2023 Q2 24,217,323 $617,976,915 +$18,360,369 $25.52 82
2023 Q1 23,544,818 $498,591,124 +$19,886,693 $21.27 88
2022 Q4 23,496,998 $695,473,237 +$39,676,033 $29.60 84
2022 Q3 23,115,252 $537,689,763 +$12,566,057 $23.26 75
2022 Q2 21,843,764 $366,307,748 -$84,215,742 $16.78 74
2022 Q1 20,152,048 $883,559,892 +$28,471,360 $43.88 98
2021 Q4 21,536,279 $1,310,815,461 +$386,735,647 $60.87 97
2021 Q3 14,210,558 $591,075,741 +$80,492,257 $41.59 68
2021 Q2 12,412,639 $376,902,461 +$30,168,286 $30.36 53
2021 Q1 11,420,900 $341,205,000 +$123,065,825 $29.87 39
2020 Q4 7,328,435 $131,544,000 -$3,975,474 $17.95 27
2020 Q3 7,550,163 $143,830,000 +$24,083,329 $19.05 18
2020 Q2 6,253,737 $98,326,000 +$4,298,931 $15.74 14
2020 Q1 5,977,254 $81,901,000 +$1,078,207 $13.65 12
2019 Q4 5,901,993 $55,657,000 -$6,870,181 $9.43 8
2019 Q3 6,446,149 $73,420,000 -$1,907,297 $11.39 11
2019 Q2 6,635,216 $66,751,000 +$66,751,089 $10.06 14